Chestnut Hill, MA, United States of America

Doron Lipson

This inventor holds 35 USPTO granted patents and 32 published patent applications, plus 1 CIPO patent and 13 EPO patents, primarily in Cancer Genomics. Top assignees: Foundation Medicine, Inc., Bio-Rad Laboratories, Inc., Bio-Rad Haifa Ltd.. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Doron Lipson. Retrieved from https://idiyas.com/inventor/doron-lipson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35 

% Patents Active = 88.6

 

 

Average Co-Inventor Count = 5.4

ph-index = 7

Forward Citations = 413(Granted Patents)


Location History:

  • Tel Aviv, IL (2012)
  • Haifa, IL (2008 - 2013)
  • Rehovot, IL (2015)
  • Newton, MA (US) (2021)
  • Chestnut Hill, MA (US) (2014 - 2023)
  • Cambridge, MA (US) (2021 - 2024)

Company Filing History:


Years Active: 2008-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Genomic Alterations
Fusion Molecules
Cholangiocarcinoma
Multigene Analysis
Estrogen Receptor
Biomarkers
Therapeutic Methods
Diagnostic Methods
Target Enrichment
Surface Plasmon Resonance
KIF5B-RET
ALK
35 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Doron Lipson

Introduction:

Doron Lipson, a renowned inventor based in Chestnut Hill, MA (US), has made significant contributions to the field of multi-gene analysis and methods for treating cholangiocarcinoma. With an impressive portfolio of 26 patents, Lipson continues to push the boundaries of innovation in the medical research domain.

Latest Patents:

1. Multigene analysis of tumor samples: Lipson's patent revolves around methods of evaluating or providing a clonal profile of a subject interval, especially in the context of tumor samples. This innovation aids in understanding genomic complexities associated with cancer.

2. Methods of treating cholangiocarcinoma: Another patent by Lipson focuses on developing novel methods and compositions for effectively treating cholangiocarcinoma, showcasing his commitment to advancing cancer therapies.

Career Highlights:

Lipson has held key positions at esteemed companies such as Foundation Medicine, Inc. and Bio-Rad Laboratories, Inc., where he has played a pivotal role in driving research and development efforts. His expertise in genomics and oncology has been instrumental in shaping cutting-edge solutions for the medical community.

Collaborations:

Throughout his career, Lipson has collaborated with industry experts such as Philip James Stephens and Roman Yelensky, fostering a culture of innovation and knowledge-sharing. These collaborative efforts have led to groundbreaking discoveries in the field of precision medicine.

Conclusion:

In conclusion, Doron Lipson's unwavering dedication to innovation and his remarkable contributions to the healthcare industry underscore his status as a trailblazing inventor. His pioneering work in multi-gene analysis and cancer treatment methodologies continues to inspire and shape the landscape of medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…